Suppr超能文献

突触囊泡蛋白2使引发的突触小泡具备对钙离子诱导的胞吐作用的能力。

SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis.

作者信息

Chang Wen-Pin, Südhof Thomas C

机构信息

Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9111, USA.

出版信息

J Neurosci. 2009 Jan 28;29(4):883-97. doi: 10.1523/JNEUROSCI.4521-08.2009.

Abstract

Synaptic vesicle protein 2 (SV2), one of the first synaptic vesicle proteins identified, is characterized by multiple transmembrane regions that exhibit homology to sugar transporters, and by a highly glycosylated intravesicular sequence. Deletion of SV2 causes postnatal lethality in mice, primarily because of fulminant epilepsy. At the cellular level, deletion of SV2 impairs neurotransmitter release, but its function is unknown, and even the exact point at which release is affected in SV2-deleted synapses remains unclear. Using electrophysiological approaches, we now examine at what step in exocytosis the deletion of SV2 impairs release. Our data demonstrate that deletion of SV2 produces a decrease in evoked synaptic responses without causing changes in mini frequency, mini amplitude, the readily releasable pool of vesicles, or the apparent Ca(2+) sensitivity of vesicle fusion. These findings indicate that a previously unidentified step may couple priming of synaptic vesicles to Ca(2+) triggering of fusion, and that SV2 acts in this step to render primed synaptic vesicles fully Ca(2+) responsive. To investigate the structural requirements for this function of SV2, we used rescue experiments. We demonstrate that conserved charged residues within the transmembrane regions and the intravesicular glycosylation of SV2 are required for its normal folding and trafficking. In contrast, the conserved putative synaptotagmin-binding sequence of SV2 is fully dispensable. Viewed together, these observations suggest that SV2 functions in a maturation step of primed vesicles that converts the vesicles into a Ca(2+)- and synaptotagmin-responsive state.

摘要

突触囊泡蛋白2(SV2)是最早被鉴定出的突触囊泡蛋白之一,其特征在于具有多个与糖转运蛋白同源的跨膜区域,以及一个高度糖基化的囊泡内序列。SV2的缺失会导致小鼠出生后死亡,主要原因是暴发性癫痫。在细胞水平上,SV2的缺失会损害神经递质的释放,但其功能尚不清楚,甚至在SV2缺失的突触中释放受影响的确切点仍不明确。我们现在使用电生理方法来研究SV2的缺失在胞吐作用的哪个步骤中损害释放。我们的数据表明,SV2的缺失会导致诱发的突触反应减少,而不会引起微小频率、微小幅度、囊泡的易释放池或囊泡融合的表观Ca(2+)敏感性的变化。这些发现表明,一个以前未被识别的步骤可能将突触囊泡的引发与Ca(2+)触发的融合联系起来,并且SV2在这个步骤中起作用,使引发的突触囊泡对Ca(2+)完全有反应。为了研究SV2此功能的结构要求,我们进行了拯救实验。我们证明,跨膜区域内保守的带电残基和SV2的囊泡内糖基化是其正常折叠和运输所必需的。相比之下,SV2保守的假定突触结合蛋白结合序列是完全不必要的。综合来看,这些观察结果表明,SV2在引发囊泡的成熟步骤中起作用,该步骤将囊泡转化为对Ca(2+)和突触结合蛋白有反应的状态。

相似文献

1
SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis.
J Neurosci. 2009 Jan 28;29(4):883-97. doi: 10.1523/JNEUROSCI.4521-08.2009.
3
Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin.
J Neurochem. 2012 Jan;120(2):248-58. doi: 10.1111/j.1471-4159.2011.07579.x. Epub 2011 Dec 2.
5
SV2 regulates neurotransmitter release via multiple mechanisms.
Am J Physiol Cell Physiol. 2010 Nov;299(5):C960-7. doi: 10.1152/ajpcell.00259.2010. Epub 2010 Aug 11.
6
Cotrafficking of SV2 and synaptotagmin at the synapse.
J Neurosci. 2010 Apr 21;30(16):5569-78. doi: 10.1523/JNEUROSCI.4781-09.2010.
8
The voltage-gated Ca2+ channel is the Ca2+ sensor of fast neurotransmitter release.
Cell Mol Neurobiol. 2001 Dec;21(6):717-31. doi: 10.1023/a:1015104105262.
9
Uncoupling the roles of synaptotagmin I during endo- and exocytosis of synaptic vesicles.
Nat Neurosci. 2011 Dec 25;15(2):243-9. doi: 10.1038/nn.3013.
10
Synaptotagmin VII as a plasma membrane Ca(2+) sensor in exocytosis.
Neuron. 2001 May;30(2):459-73. doi: 10.1016/s0896-6273(01)00290-2.

引用本文的文献

1
4
5
Synaptic Vesicle Glycoprotein 2C: a role in Parkinson's disease.
Front Cell Neurosci. 2024 Sep 5;18:1437144. doi: 10.3389/fncel.2024.1437144. eCollection 2024.
6
Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming.
Science. 2024 Aug 2;385(6708):adl2992. doi: 10.1126/science.adl2992.
7
Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression.
Neuropsychopharmacology. 2024 Nov;50(1):153-163. doi: 10.1038/s41386-024-01913-3. Epub 2024 Jul 22.
9
SV2A PET imaging in human neurodegenerative diseases.
Front Aging Neurosci. 2024 Apr 18;16:1380561. doi: 10.3389/fnagi.2024.1380561. eCollection 2024.
10
Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A.
Nat Commun. 2024 Apr 18;15(1):3027. doi: 10.1038/s41467-024-47322-4.

本文引用的文献

1
A dual-Ca2+-sensor model for neurotransmitter release in a central synapse.
Nature. 2007 Nov 29;450(7170):676-82. doi: 10.1038/nature06308.
2
Monitoring synaptic transmission in primary neuronal cultures using local extracellular stimulation.
J Neurosci Methods. 2007 Mar 30;161(1):75-87. doi: 10.1016/j.jneumeth.2006.10.009. Epub 2006 Nov 21.
3
The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves.
FEBS Lett. 2006 Apr 3;580(8):2011-4. doi: 10.1016/j.febslet.2006.02.074. Epub 2006 Mar 7.
4
SV2 is the protein receptor for botulinum neurotoxin A.
Science. 2006 Apr 28;312(5773):592-6. doi: 10.1126/science.1123654. Epub 2006 Mar 16.
5
Synaptic vesicle protein 2 enhances release probability at quiescent synapses.
J Neurosci. 2006 Jan 25;26(4):1303-13. doi: 10.1523/JNEUROSCI.2699-05.2006.
7
SV2A and SV2C contain a unique synaptotagmin-binding site.
Mol Cell Neurosci. 2005 May;29(1):56-64. doi: 10.1016/j.mcn.2004.12.011.
8
SV2B regulates synaptotagmin 1 by direct interaction.
J Biol Chem. 2004 Dec 10;279(50):52124-31. doi: 10.1074/jbc.M407502200. Epub 2004 Oct 5.
9
The synaptic vesicle cycle.
Annu Rev Neurosci. 2004;27:509-47. doi: 10.1146/annurev.neuro.26.041002.131412.
10
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.
Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9861-6. doi: 10.1073/pnas.0308208101. Epub 2004 Jun 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验